Dexcom (DXCM) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.47% |
| Dec 31, 2025 | 24.80% |
| Sep 30, 2025 | 26.08% |
| Jun 30, 2025 | 30.55% |
| Mar 31, 2025 | 31.57% |
| Dec 31, 2024 | 33.06% |
| Sep 30, 2024 | 34.38% |
| Jun 30, 2024 | 36.12% |
| Mar 31, 2024 | 38.01% |
| Dec 31, 2023 | 43.47% |
| Sep 30, 2023 | 44.78% |
| Jun 30, 2023 | 47.04% |
| Mar 31, 2023 | 47.82% |
| Dec 31, 2022 | 48.62% |
| Sep 30, 2022 | 49.09% |
| Jun 30, 2022 | 49.80% |
| Mar 31, 2022 | 47.33% |
| Dec 31, 2021 | 48.94% |
| Sep 30, 2021 | 53.04% |
| Jun 30, 2021 | 54.42% |
| Mar 31, 2021 | 55.02% |
| Dec 31, 2020 | 56.61% |
| Sep 30, 2020 | 58.20% |
| Jun 30, 2020 | 56.76% |
| Mar 31, 2020 | 57.51% |
| Dec 31, 2019 | 59.42% |
| Sep 30, 2019 | 60.80% |
| Jun 30, 2019 | 57.65% |
| Mar 31, 2019 | 57.42% |
| Dec 31, 2018 | 54.65% |
| Sep 30, 2018 | 53.81% |
| Jun 30, 2018 | 52.36% |
| Mar 31, 2018 | 52.79% |
| Dec 31, 2017 | 50.43% |
| Sep 30, 2017 | 48.87% |
| Jun 30, 2017 | 47.73% |
| Mar 31, 2017 | 50.08% |
| Dec 31, 2016 | 48.79% |
| Sep 30, 2016 | 47.82% |
| Jun 30, 2016 | 44.99% |
| Dec 31, 2015 | 38.42% |